Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Novithera

Novithera
2016 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Developer of a cancer immuno-therapeutics designed to exploit kinase for the development of small molecule.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Strasbourg
  • France
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Novithera’s full profile, request a free trial.

Novithera Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator Completed Startup
1. Joint Venture 24-Oct-2016 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Novithera Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
SEMIA Incubateur d' Alsace Accelerator/Incubator Minority 000 0000 000000 0

Novithera Executive Team (1)

Name Title Board
Seat
Contact
Info
Luc Van Hijfte President & Chief Executive Officer